European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research

Thomas Lehner; Michael Hoelscher; Mario Clerici; Frances Gotch; Louise Pedneault; Jim Tartaglia; Clive Gray; Jiri Mestecky; Quentin Sattentau; Janneke Van De Wijgert; Coumba Toure; Saladin Osmanov; Reinold E. Schmidt; Patrice Debre; Manuel Romaris; Arnd Hoeveler; Simonetta di Fabio

doi:10.1016/j.vaccine.2005.07.009

European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research

Thomas Lehner
, Michael Hoelscher
, Mario Clerici
, Frances Gotch
, Louise Pedneault
, Jim Tartaglia
, Clive Gray
, Jiri Mestecky
, Quentin Sattentau
, Janneke Van De Wijgert
, Coumba Toure
, Saladin Osmanov
, Reinold E. Schmidt
, Patrice Debre
, Manuel Romaris
, Arnd Hoeveler
, Simonetta di Fabio

Clinical Genetics Guys and St Thomas’ NHS Foundation Trust, Guys Hospital, London, UK
Ludwig Maximilian University of Munich
University of Milan
Chelsea and Westminster Hospital
GlaxoSmithKline
Sanofi Pasteur Limited
National Institute for Communicable Diseases
Vaccine Centre
University of Oxford
International Antiviral Therapy Evaluation Center
World Health Organization
Hannover Medical School
CNRS
European Commission

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations. © 2005 Elsevier Ltd. All rights reserved.

Original language	English
Pages (from-to)	5551-5556
Journal	Vaccine
Volume	23
Issue number	48-49
DOIs	https://doi.org/10.1016/j.vaccine.2005.07.009
Publication status	Published - 1 Dec 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.vaccine.2005.07.009

Cite this

Lehner, T., Hoelscher, M., Clerici, M., Gotch, F., Pedneault, L., Tartaglia, J., Gray, C., Mestecky, J., Sattentau, Q., Wijgert, J. V. D., Toure, C., Osmanov, S., Schmidt, R. E., Debre, P., Romaris, M., Hoeveler, A., & di Fabio, S. (2005). European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research. Vaccine, 23(48-49), 5551-5556. https://doi.org/10.1016/j.vaccine.2005.07.009

@article{2c067ba34b984e7e975792ebfaaa22bc,

title = "European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research",

abstract = "The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations. {\textcopyright} 2005 Elsevier Ltd. All rights reserved.",

author = "Thomas Lehner and Michael Hoelscher and Mario Clerici and Frances Gotch and Louise Pedneault and Jim Tartaglia and Clive Gray and Jiri Mestecky and Quentin Sattentau and Wijgert, \{Janneke Van De\} and Coumba Toure and Saladin Osmanov and Schmidt, \{Reinold E.\} and Patrice Debre and Manuel Romaris and Arnd Hoeveler and \{di Fabio\}, Simonetta",

year = "2005",

month = dec,

day = "1",

doi = "10.1016/j.vaccine.2005.07.009",

language = "English",

volume = "23",

pages = "5551--5556",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "48-49",

}

Lehner, T, Hoelscher, M, Clerici, M, Gotch, F, Pedneault, L, Tartaglia, J, Gray, C, Mestecky, J, Sattentau, Q, Wijgert, JVD, Toure, C, Osmanov, S, Schmidt, RE, Debre, P, Romaris, M, Hoeveler, A & di Fabio, S 2005, 'European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research', Vaccine, vol. 23, no. 48-49, pp. 5551-5556. https://doi.org/10.1016/j.vaccine.2005.07.009

TY - JOUR

T1 - European Union and EDCTP strategy in the global context

T2 - Recommendations for preventive HIV/AIDS vaccines research

AU - Lehner, Thomas

AU - Hoelscher, Michael

AU - Clerici, Mario

AU - Gotch, Frances

AU - Pedneault, Louise

AU - Tartaglia, Jim

AU - Gray, Clive

AU - Mestecky, Jiri

AU - Sattentau, Quentin

AU - Wijgert, Janneke Van De

AU - Toure, Coumba

AU - Osmanov, Saladin

AU - Schmidt, Reinold E.

AU - Debre, Patrice

AU - Romaris, Manuel

AU - Hoeveler, Arnd

AU - di Fabio, Simonetta

PY - 2005/12/1

Y1 - 2005/12/1

N2 - The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations. © 2005 Elsevier Ltd. All rights reserved.

AB - The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations. © 2005 Elsevier Ltd. All rights reserved.

UR - https://www.scopus.com/pages/publications/27744590448

UR - https://www.ncbi.nlm.nih.gov/pubmed/16153752

U2 - 10.1016/j.vaccine.2005.07.009

DO - 10.1016/j.vaccine.2005.07.009

M3 - Article

C2 - 16153752

SN - 0264-410X

VL - 23

SP - 5551

EP - 5556

JO - Vaccine

JF - Vaccine

IS - 48-49

ER -

European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this